Peter M Hecht
Director, 10% owner at Cyclerion Therapeutics, Inc. (KRSA)
Peter M Hecht has filed 8 insider reports with the SEC since May 2021, as director and 10% owner at Cyclerion Therapeutics, Inc. (KRSA). Peter M Hecht made no open-market purchases or sales in the last 12 months. The latest filing, on July 20, 2026, reports conversion of a derivative at Cyclerion Therapeutics, Inc. (KRSA).
- Filings
- 8
- Companies
- 1
- Bought on market
- $2.43M
- Sold on market
- None
Companies where Peter M Hecht is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director, 10% owner | 910,240 | $2.43M | $2.43 | $37.56+1446% | Jul 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jul 16, 2026KRSADirector Hecht Peter M converted options into 351,037 shares, increasing direct ownership by 63% to 910,240 unitsForm 4Conversion of a derivative
- Mar 25, 2025KRSADirector Hecht Peter M was granted 181,818 shares, increasing direct ownership by 48% to 559,203 unitsForm 4Grant or award
- Jan 1, 2024KRSAHecht Peter M was granted 15,000 shares, increasing direct ownership by 4% to 377,385 unitsForm 4Grant or award
- Dec 1, 2023KRSAHecht Peter M was granted 35,000 shares, increasing direct ownership by 11% to 362,385 unitsForm 4Grant or award
- May 19, 2023KRSASEC Form 4 filed by Hecht Peter MForm 4Grant or award
- Jan 20, 2022KRSASEC Form 4 filed by Hecht Peter MForm 4Grant or award
- May 6, 2021+$734KKRSASEC Form 4: Hecht Peter M bought $733,860 worth of Common Stock (302,000 units at $2.43), increasing direct ownership by 33% to 1,224,528 unitsForm 4Open-market purchase
- May 5, 2021+$1.69MKRSASEC Form 4: Hecht Peter M bought $1,693,943 worth of Common Stock (698,001 units at $2.43), increasing direct ownership by 311% to 922,528 unitsForm 4Open-market purchase
Compare Peter M Hecht with
- Peter M Hecht vs Rhonda M. Chicko1 shared
- Peter M Hecht vs Michelle Patricia Pernice1 shared
- Peter M Hecht vs Nimish P Shah1 shared
- Peter M Hecht vs Andrew Gottesdiener1 shared
- Peter M Hecht vs Jonathan Violin1 shared
- Peter M Hecht vs Heidi Henson1 shared
Other insiders at the same companies
- Rhonda M. ChickoKRSA
- Michelle Patricia PerniceKRSA
- Nimish P ShahKRSA
- Fairmount Funds Management LLCKRSA
- Andrew GottesdienerKRSA
- Jonathan ViolinKRSA
- Matthew James LeoniKRSA
- Heidi HensonKRSA
- Mark J. VignolaKRSA
- Regina Margaret GraulKRSA
- Michael J HigginsKRSA
- Slate Path Capital LPKRSA
Questions about Peter M Hecht
- What is Peter M Hecht's role at Cyclerion Therapeutics, Inc.?
- Peter M Hecht reports to the SEC as director and 10% owner at Cyclerion Therapeutics, Inc. (KRSA), according to the latest filing on July 20, 2026.
- How many shares does Peter M Hecht own?
- After the latest filing that states it, Peter M Hecht directly owned 910,240 shares of Cyclerion Therapeutics, Inc. (KRSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter M Hecht bought or sold stock recently?
- The most recent open-market purchase was on May 6, 2021: bought 302,000 shares of Cyclerion Therapeutics, Inc. (KRSA) for $734K at an average of $2.43.
- How do I get alerts when Peter M Hecht files?
- Follow Peter M Hecht on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Peter M Hecht (SEC CIK 0001478485). Totals count each trade once, skipping amendments whose original is on file, from May 7, 2021 on. View on SEC EDGAR · Get this as JSON